Cologuard Plus review

Choose a screening pathway, not just a kit

Cologuard Plus can be a reasonable screening option for an eligible adult who wants at-home collection and is prepared to complete follow-up. Its central tradeoff is unavoidable: a positive result needs colonoscopy. A kit that is easier to start is only useful if the rest of the pathway remains accessible. ^[1]

This purchase is different from buying a wellness dashboard. The result may create a clinical decision with real scheduling and payment consequences. Before requesting the test, identify who will receive the result and arrange the next step if needed. Prefer a screening method you can complete over a theoretically attractive option that leaves you stranded after the laboratory report.

Eligibility is more specific than the age threshold

The official labeling describes Cologuard and Cologuard Plus for average-risk adults aged 45 and older and says the products are prescription only. It excludes several histories, including prior adenomas, inflammatory bowel disease, and personal or first-degree family history of colorectal cancer. It is not a substitute for diagnostic or surveillance colonoscopy in high-risk people. ^[1]

That makes family and personal history part of the decision before the box is ordered. Do not treat a convenient collection method as a workaround for a different recommended assessment. The same principle applies if the reason for testing is a symptom rather than routine screening: the clinician needs to establish the appropriate pathway, because a screening result cannot settle every concern.

For the evidence behind this decision, read Stool DNA screening: cancer sensitivity is only one decision.

Cancer detection and prevention are different promises

The next-generation BLUE-C study evaluated stool DNA and hemoglobin markers against screening colonoscopy. It reported 93.9% sensitivity for colorectal cancer but 43.4% for advanced precancerous lesions. It found higher sensitivity and lower specificity than the FIT used in that study. Exact Sciences funded the research. ^[2]

Those results explain both the appeal and the limit. A high cancer-detection percentage is not the chance that your own positive result means cancer, and it does not mean that nearly all important precursors are detected. The study also does not establish a head-to-head lifetime-outcome advantage over every alternative screening program. Keep the test generation clear rather than combining older Cologuard and newer assay figures into one claim.

Payment and follow-up decide the real value

No single patient payment is established here. Get the prescribed test name, laboratory coverage and any out-of-pocket amount from the applicable plan and service. Consider access to follow-up colonoscopy alongside the initial test. Do not interpret an attractive upfront arrangement as proof that all later care is included.

The manufacturer warns that both false positives and false negatives occur. A positive result does not confirm cancer, and a negative result does not establish its absence. It also instructs people not to provide a sample with diarrhea or blood in urine or stool. ^[1] Follow the supplied instructions and the ordering clinician’s advice. Compare FIT and colonoscopy within that conversation. Cologuard Plus earns consideration when the eligibility, collection format and complete follow-up plan fit together; ease of ordering alone is too small a basis for the choice.

Keep a copy of the result and the exact test name in your health record. Screening is not finished simply because a shipment arrived or a sample was returned. The next decision depends on the result and your circumstances. If the collection format is the main appeal, compare that convenience with your willingness to carry through the subsequent clinical steps before deciding that this is the easiest option overall.

A connected consideration is Preventive blood panels: when more tests change a decision. It answers a different part of the decision.

Understanding the cost

Patient-specific laboratory payment, insurance coverage and follow-up colonoscopy costs not established. Obtain coverage information for the prescribed test and downstream care.